• About
  • Advertise
  • Privacy & Policy
  • Contact
HK Businesswire
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Medisafe Scandal Deepens as HK Institutions Deny Outsourcing, Despite Contradictory Interview, Vendor Evidence and Whistleblower Claims

    Geneva Invention Awards Respond to Medisafe Scandal: ‘We Will Engage Our Own Panel to Determine Any Action’

    Deloitte: Over 40% of Family Offices Prioritise Tech Amid Digital Transformation

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

    Xiaomi SU7 Ultra Becomes Fastest Mass-Produced EV on Nürburgring Nordschleife

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
  • Home
  • News
    • All
    • Business
    • Politics
    • PR Newswire
    • Science
    • World
    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    TIER IV unveils end-to-end architecture for Level 4+ autonomy: To be demonstrated across 50 locations nationwide

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Global Times: Xi’s vision of a people-centered city guides China’s urban development

    Trending Tags

    • Trump Inauguration
    • United Stated
    • White House
    • Market Stories
    • Election Results
  • PR Newswire
  • Business
  • World
  • Entertainment
  • Sports
  • Tech
    • All
    • Apps
    • Gadget
    • Mobile
    • Startup

    Medisafe Scandal Deepens as HK Institutions Deny Outsourcing, Despite Contradictory Interview, Vendor Evidence and Whistleblower Claims

    Geneva Invention Awards Respond to Medisafe Scandal: ‘We Will Engage Our Own Panel to Determine Any Action’

    Deloitte: Over 40% of Family Offices Prioritise Tech Amid Digital Transformation

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    PwC: AI-Exposed Jobs See Surge in Demand, Pay, and Productivity

    Hong Kong Student Criticised for Using Outsourced AI Project to Win STEM Awards

    Xiaomi SU7 Ultra Becomes Fastest Mass-Produced EV on Nürburgring Nordschleife

    Trending Tags

    • Nintendo Switch
    • CES 2017
    • Playstation 4 Pro
    • Mark Zuckerberg
  • Feature
No Result
View All Result
HK Businesswire
No Result
View All Result
Home News PR Newswire

Pop Singer Kelly Yu Releases World’s First AI Anime Music Video for Song “Werewolf” in Collaboration with CreateAI

PR Newswire by PR Newswire
16 April 2025
in PR Newswire
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

TOKYO and BEIJING, April 16, 2025 /PRNewswire/ — In an unprecedented fusion of technology and artistry, renowned Chinese-Canadian Singer and Actress Kelly Yu has teamed up with CreateAI (OTCMKTS: TSPH) (“CreateAI” or the “Company”), a global artificial intelligence company, to produce a revolutionary music video for her new single “Werewolf.” The partnership signifies the first time a music video by a major recording artist has been created from concept to completion employing generative AI.

The collaboration also highlights the power of the combined efforts of human directors, production artists, and a cutting-edge generative AI model, bringing Ms. Yu’s creative vision to life in a way never seen before. Through leveraging CreateAI’s model, the creative team seamlessly integrated human drawn key-frames and direction with AI-generated videos, resulting in fine detail and nuance perfectly buttressing the song’s emotional depth and complexity.

The three-and-a-half-minute video presents an air of dark mystery, offering a shadowy theme of a fairy tale with elements such as castles, forests, werewolves, and romance. The male and female protagonists use dance to weave a story of desire. Unlike past AI-generated videos, the difficult dance moves in the film are presented in a more refined manner, with consistent and fine facial characteristics seen in the characters.

Kelly Yu said, “I’m thrilled to be at the forefront of this groundbreaking project. Collaborating with CreateAI has allowed us to really push the boundaries of what’s possible in music video production while also capturing the vision I’ve been wanting to present for quite some time. I hope audiences enjoy this work as much as I do.”

CreateAI is unique in offering an integrated approach at the intersection of generative AI and digital entertainment creation. The Company seeks to attract top tier creative talent and nurture a positive community ecosystem that benefits creative industries while generating long-term sustainable advantage. The technology employed for “Werewolf” shortened the video production time by nearly 50% while saving RMB millions in development costs.

“We are grateful to Kelly for working with us and allowing us to showcase our technology,” said Cheng Lu, CEO of CreateAI. “Our goal is to empower artists by providing them with the tools and technology needed to bring their creative visions to life. This music video is a perfect example of how generative AI can enhance human creativity and produce something unique and captivating.”

The “Werewolf” music video will be distributed across major music streaming platforms, making it accessible to a global audience. This innovative project sets a new standard for music video production and opens up exciting possibilities for future collaborations between artists and AI. At present, the work is being considered for award selection at the Beijing International Film Festival.

About CreateAI

CreateAI (formerly TuSimple) is a global applied artificial intelligence company with offices in the US, China, and Japan. The Company has developed leading AI technology for a number of end-use applications. The Company is pioneering the future of digital entertainment content production, seamlessly blending cutting-edge generative AI technology with the creativity of world-class talent. Our mission is to redefine the boundaries of what’s possible in digital storytelling by developing immersive, captivating, and visually stunning experiences that resonate with audiences on a global scale. 

CreateAI Media Contact:
Email: CreateAI.PR@icrinc.com  

Tags: prnewswire
PR Newswire

PR Newswire

PR Newswire is the industry’s leading press release distribution partner with an unparalleled global reach of more than 440,000 newsrooms, websites, direct feeds, journalists and influencers and is available in more than 170 countries and 40 languages. From our award-winning Content Services offerings, integrated media newsroom and microsite products, Investor Relations suite of services, paid placement and social sharing tools, PR Newswire has a comprehensive catalog of solutions to solve the modern-day challenges PR and communications teams face. For 70 years, PR Newswire has been the preferred destination for brands to share their most important news stories across the world.

Read More

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
  • Trending
  • Comments
  • Latest
CreateAI Advances Generative AI Technology with Two Papers Accepted at Prestigious ICCV 2025

CreateAI Advances Generative AI Technology with Two Papers Accepted at Prestigious ICCV 2025

2 July 2025
Taylor’s University Continues Strong Global Performance in QS World University Rankings 2026

Taylor’s University Continues Strong Global Performance in QS World University Rankings 2026

23 June 2025

PwC: Hong Kong Set to Reclaim Global IPO Crown in 2025 as Fundraising Surges

3 July 2025
FORTUNE UNVEILS 2025 SOUTHEAST ASIA 500

FORTUNE UNVEILS 2025 SOUTHEAST ASIA 500

17 June 2025
Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

16 July 2025
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

16 July 2025

Recent News

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer

16 July 2025
JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

JSRPM Leverages AI and Advanced Machining to Counter Tariff Pressures

16 July 2025
AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

AbbVie’s 10th ‘Week of Possibilities’ Unites Employees Across Asia for Community Impact

16 July 2025
ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

ArkBio’s Ziresovir Included into Pediatric RSV Drug Priority List by WHO

16 July 2025
HK Businesswire

Stay ahead with the latest insights on Hong Kong’s economy, finance, and investments. From market trends to policy updates, we bring you in-depth analysis and expert opinions.

📩 Subscribe to our newsletter for exclusive updates.
📍 Follow us on social media for real-time news.
📧 Contact us: info@hongkong-invest.com

Follow Us

  • About
  • Advertise
  • Privacy & Policy
  • Contact

© 2025 by HKBusinesswire.com

No Result
View All Result

© 2025 by HKBusinesswire.com